Neurocysticercosis (NCC), a central nervous system (CNS) infection with Taenia solium (pork tapeworm), is a leading infectious cause of epilepsy in endemic areas. Treating T. solium taeniasis with anthelminthic medications (AHMs) like niclosamide or praziquantel (PZQ) is essential to prevent NCC. However, co-infections of taeniasis with viable NCC, the presence of living CNS cysts, impose a risk of neurological adverse events with PZQ, complicating treatment decisions. The availability and type of AHMs and lack of feasible diagnostic methods for NCC in community settings is a major challenge in informing anthelminthic treatment decisions, warranting exploration of NCC prevalence among people with taeniasis. This study aimed to describe the prevalence of taeniasis in screened communities and the prevalence of NCC, along with key characteristics, among people with confirmed taeniasis from northern Peru.